Arphra
live
S&P 5007,500.58+1.08%
NASDAQ30,406.19+2.48%
DOW51,564.7+0.14%
VIX16.78+2.32%
US10Y4.45-0.27%
EUR/USD1.1506-0.93%
GOLD4,300.5-1.26%
WTI75.22-0.90%
BTC64,442.01-1.87%
S&P 5007,500.58+1.08%
NASDAQ30,406.19+2.48%
DOW51,564.7+0.14%
VIX16.78+2.32%
US10Y4.45-0.27%
EUR/USD1.1506-0.93%
GOLD4,300.5-1.26%
WTI75.22-0.90%
BTC64,442.01-1.87%

PODD

Insulet Corporation
HealthcareMedical - DevicesUSUSDPeers →
$138.97
+0.77%LiveJun 22, 2026
AI Brief
Market cap
$9.63B
52w range
138.79 – 354.88
P / E
—
EPS · FY 2025
$3.48
Volume
1.64M
Revenue · FY 2025
$2.71B
+30.73% YoY
OverviewFundamentalsValuationMarketOwnership & flowNarrative & AI
PricesTrendEarningsEstimatesCall languageAnalystsRelated securities

Explain this page

Arphra AI
Equity listings
1
Corporate bonds
0
Convertibles
0
Peer equities
10
Equity
· 1 venue

Cross-listings

SymbolExchangeCtryCcyMkt cap
PODDprimaryNasdaq Stock MarketusUSD$10.1B
Listed options →
Equity
· 10 names

Peer companies

  • BIIBBiogen Inc.$27.62B
  • PHGKoninklijke Philips N.V.$24.89B
  • DXCMDexCom, Inc.$23.67B
  • DGXQuest Diagnostics Incorporated$21.33B
  • WSTWest Pharmaceutical Services, Inc.$21.24B
  • LHLabcorp Holdings Inc.$21.06B
  • STESTERIS plc$21.04B
  • WATWaters Corporation$18.28B
  • ZBHZimmer Biomet Holdings, Inc.$16.05B
  • SNNSmith & Nephew plc$13.3B
Fixed income
· no mapped debt

Corporate bonds

No corporate bonds mapped to this issuer’s LEI. Many equity-only names carry no public debt, or the LEI bridge isn’t resolved yet.

AI read · securities complex

Arphra AI